Participated · Equity · Jun 2026

Ionic Digital positions itself as a fast-track provider of high-performance computing (HPC) and data center infrastructure designed for intensive AI workloads. The company emphasizes delivering fully ready assets, scalability, and speed to market to address industry bottlenecks such as constrained power and long development timelines. Ionic Digital highlights a seasoned management team with experience developing hundreds of megawatts and raising billions in capital. The company recently strengthened its financial position by completing a $400 million equity private placement that values the business at a $2.0 billion pre-money valuation. Management stated the new capital will support continued development of its digital infrastructure assets and the company’s broader platform strategy.

Led · Equity · Jun 2026

OliX develops RNAi therapeutics using its OASIS (OliX Advanced Small Interfering RNA System) platform designed to enhance gene-silencing efficiency and enable tissue-specific delivery. Using OASIS, the company is advancing programs for indications including hair loss, age-related macular degeneration, hypertrophic scars, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and cardiometabolic disorders. Under its “OliX 2.0 Roadmap,” the company is also developing next-generation delivery technologies targeting the central nervous system and adipose tissue while expanding its pipeline of RNAi-based therapies. The recent financing with BOLD and Weiss is intended to accelerate these development programs and strengthen research capabilities. The partnership with L’Oréal via BOLD is positioned as strategic, combining OliX’s siRNA platform with L’Oréal’s expertise in biology, tech, and formulation. OliX has framed the investment as validation of its technological competitiveness and growth potential.